You have 9 free searches left this month | for more free features.

Liposarcoma, Myxoid

Showing 26 - 50 of 113

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Liposarcoma Trial in United States (efatutazone)

Active, not recruiting
  • Liposarcoma
  • Little Rock, Arkansas
  • +126 more
Aug 16, 2021

Sarcoma, Soft Tissue Trial in Shanghai (Sintilimab, Doxorubicin Hydrochloride, Ifosfamide)

Recruiting
  • Sarcoma, Soft Tissue
  • Shanghai, Shanghai, China
    Fudan University, Cancer Hospital
Jul 13, 2020

Myxoid Liposarcoma, Round Cell Liposarcoma, Stage III Soft Tissue Sarcoma AJCC v7 Trial in Seattle (procedure, other, drug)

Withdrawn
  • Myxoid Liposarcoma
  • +5 more
  • Biopsy
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 6, 2019

Myxoid Liposarcoma Trial in Warsaw (Hypofractionated radiotherapy)

Active, not recruiting
  • Myxoid Liposarcoma
  • Hypofractionated radiotherapy
  • Warsaw, Mazovian, Poland
    Maria Sklodowska-Curie Institute - Oncology Center
Jun 14, 2019

Myxoid Liposarcoma, Round Cell Liposarcoma, Synovial Sarcoma Trial in Seattle (Laboratory Biomarker Analysis, Recombinant

Terminated
  • Myxoid Liposarcoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Recombinant Interferon Gamma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 19, 2019

Sarcoma Trial in Worldwide (RG1507)

Terminated
  • Sarcoma
  • Duarte, California
  • +40 more
Jan 14, 2021

Sarcoma,Soft Tissue Trial in France (Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery, 2 cycles of

Recruiting
  • Sarcoma,Soft Tissue
  • Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery
  • +2 more
  • Bordeaux, France
  • +4 more
Mar 28, 2022

Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults Trial in Italy, Spain (epirubicin 60

Active, not recruiting
  • Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
  • epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)
  • +5 more
  • Candiolo, TO, Italy
  • +14 more
Nov 15, 2021

Sarcoma Trial in Toulouse (Blood samples will be collected at two times :)

Completed
  • Sarcoma
  • Blood samples will be collected at two times :
  • Toulouse, France
    Institut Universitaire du Cancer de Toulouse - Oncopole
Dec 9, 2021

Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel (lete-cel, GSK3377794)
  • +2 more
  • Duarte, California
  • +36 more
Oct 28, 2022

Liposarcoma, Atypical Lipomatous Tumor Trial in Montpellier (Blood sampling)

Recruiting
  • Liposarcoma
  • Atypical Lipomatous Tumor
  • Blood sampling
  • Montpellier, France
    Institut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022

Mesenchymal Chondrosarcoma Trial in Italy (Trabectedin)

Active, not recruiting
  • Mesenchymal Chondrosarcoma
  • Prato, Firenze, Italy
  • +5 more
Oct 29, 2021

Engagement Patterns and Participation Trends Among Liposarcoma

Not yet recruiting
  • Liposarcoma
    • San Francisco, California
      Power Life Sciences
    Sep 8, 2023

    Liposarcoma, Dedifferentiated Trial in Worldwide (BI 907828, Doxorubicin)

    Recruiting
    • Liposarcoma, Dedifferentiated
    • Birmingham, Alabama
    • +131 more
    Feb 2, 2023

    Dedifferentiated Liposarcoma Patients in China

    Not yet recruiting
    • Dedifferentiated Liposarcoma
      • Beijing, China
        Beijing Jishuitan hospital
      Oct 30, 2023

      Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

      Active, not recruiting
      • Sarcoma, Soft Tissue
      • Changsha, Hunan, China
        Xiangya Hospital Central South University
      Oct 29, 2023

      Status of Surgical Resection and Histologic Subtype as

      Completed
      • Liposarcoma of Soft Tissue
      • Surgical Procedure, Unspecified
      • Retroperitoneal Liposarcoma resection
      • São Paulo, Brazil
        Hospital das Clínicas da Faculdade de Medicina da Universidade d
      Jun 18, 2022

      Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

      Active, not recruiting
      • Liposarcoma
      • Metastatic Liposarcoma
      • Boston, Massachusetts
      • +2 more
      Nov 23, 2022

      Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)

      Completed
      • Dedifferentiated Liposarcoma
      • Los Angeles, California
      • +70 more
      Jan 5, 2023

      Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

      Not yet recruiting
      • Advanced Dedifferentiated Liposarcoma
      • +5 more
      • (no location specified)
      Jan 11, 2023

      Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)

      Active, not recruiting
      • Ovarian Cancer
      • +3 more
      • Duarte, California
      • +6 more
      Jan 21, 2023

      Dedifferentiated Liposarcoma Trial in Beijing, Shanghai (TQB3616 capsule, TQB3616 )

      Not yet recruiting
      • Dedifferentiated Liposarcoma
      • TQB3616 capsule
      • TQB3616 placebo
      • Beijing, Beijing, China
      • +2 more
      Aug 9, 2022

      Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

      Available
      • Glioblastoma
      • +13 more
      • (no location specified)
      Jul 26, 2023

      Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma Trial in Worldwide (Surgery, Preoperative chemo)

      Recruiting
      • Retroperitoneal Sarcoma
      • +2 more
      • Surgery
      • Preoperative chemotherapy
      • Woolloongabba, Queensland, Australia
      • +36 more
      Dec 27, 2022